Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği

Size: px
Start display at page:

Download "Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği"

Transcription

1

2 Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği Leigh Delbridge President, International Association of Endocrine Surgeons Professor and Head of Surgery, The University of Sydney 25 th April 17:20 (40 minutes)

3 paradigm shift there has been a paradigm shift in the management of differentiated thyroid cancer over the last decade, specifically related to the management of lymph nodes in papillary thyroid cancer delayed recognition that the long standing Asian approach of routine cervical lymph node dissection impacts outcomes papillary cancer is now primarily a surgical disease with relegation of the role of radioiodine ablation

4 Japanese approach 25 years ago routine neck dissection is the best treatment for patients >40 yrs with primary tumours 1.5 cm in size whether or not nodes are clinically palpable. With this recurrence free survival rate can be improved substantially Noguchi S, Murakami N. Surg Clin North Am 1987;67:251

5 Western approach 25 years ago prophylactic removal of regional lymph nodes, with or without metastases, does not improve cure rates there is an inverse relationship between lymph node metastases and survival rate in thyroid cancer such that the more frequent the number of nodal metastases, the better the prognosis Cady B. Arch Surg 1984;119:1067 everyone who works with papillary thyroid cancer knows that most of the patients have lymph node metastases. We also know that they do not have any bearing on outcome Cady B. World J Surg 1994;18:558

6 risk stratification development of various risk stratification systems to identify low risk vs high risk patients none of these systems incorporated involved lymph nodes AGES age grade extent size AMES age dist mets extent size DAMES age dist mets extent size diploid GAMES age grade dist mets extent size MACIS age dist mets (invas) size completeness

7 SCNA 2009 total thyroidectomy is now accepted as standard care clinically evident disease requires formal compartment oriented therapeutic lymph node dissection prophylactic central lymph node remains controversial but dissection should be considered for most patients with papillary thyroid cancer Suliburk J, Delbridge L. SCNA 2009; 89:1171

8 revised ATA guidelines AIM: to remove the tumor, disease that has extended beyond the capsule and involved cervical lymph nodes. WHY: completeness of resection is an important determinant of outcome whilst residual metastatic lymph nodes represent the most common site of recurrence/persistence Cooper DS, Doherty GM, Haugen BR et al. Thyroid 2009;19:

9 lecture outline NECK DISSECTION FOR PAPILLARY CANCER definitions: therapeutic vs prophylactic central vs lateral unilateral vs bilateral summary of evidence what is the best operation? surgical technique: video of steps

10 therapeutic vs prophylactic ATA/AAES consensus statement definitions a therapeutic neck dissection implies that nodal metastasis is apparent clinically (pre operatively or intra operatively) or by imaging a prophylactic neck dissection implies that nodal metastasis is not detected clinically or by imaging (clinically N0) Carty SE, Cooper DS, Doherty GM et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19:1153

11 central vs lateral esophagus RLN innominate vein

12 what really is the central neck? numerous descriptions of the central compartment considerable variation in clinical practice from removal of just level VI paratracheal nodes through to removal of all tissue between both carotid arteries from hyoid to innominate vein

13 the four groups of lymph nodes in the central (level VI) compartment are: prelaryngeal (Delphian) nodes pretracheal lymph nodes the right and left paratracheal nodes including any retropharyngeal or retro oesophageal nodes. Carty SE, Cooper DS, Doherty GM et al. Thyroid 2009;19:1153

14 level VII retromanubrial nodes are simply the in continuity inferior extension of pretracheal nodes to the innominate vein and should logically be considered as part of the central compartment Sydney practice is to include Level VII

15 unilateral vs bilateral central neck dissection (CND) includes a comprehensive, compartment oriented removal of: 1. pre laryngeal nodes 2. pretracheal nodes 3. at least one paratracheal node basin. unilateral CND = removal of one paratracheal compartment on the side of the tumour bilateral CND = removal of both paratracheal compartments Carty SE, Cooper DS, Doherty GM et al. Thyroid 2009;19:1153

16 overview therapeutic lateral for clinically evident disease central for clinically evident disease prophylactic lateral defies the logic of prophylaxis central controversial area with need to balance risks and benefits

17 rationale of prophylactic surgery the rationale for prophylactic node dissection at the time of total thyroidectomy is that this provides the best opportunity to achieve safe nodal clearance. Re entering the central compartment for a therapeutic at a later stage poses increased risks of complications. Unnecessary for the majority of patients so risks must be minimal. absolutely no logic to prophylactic lateral node dissection, as there is no increased risk to undertaking therapeutic lateral node dissection, if required, as a secondary procedure only potential benefit is upstaging

18 the current major area of controversy therefore surrounds the relative risks versus the potential benefits of prophylactic central neck dissection for N0 patients primum, non nocere first, do no harm approach must be to balance risks and benefits

19 total thyroidectomy alone no prophylactic CND nodal persistence small operative risks

20 standard of care until recently reduces risk of local recurrence removes of multifocal disease allows radioiodine ablation facilitates follow up with Tg removes risk of de differentiation avoids risks of re operative surgery Sosa JA, Udelsman R. J Surg Oncol. 2006;94:701 7

21 total thyroidectomy alone regional nodes present in 20 to 90% of patients in many cases these nodes do not appear abnormal to inspection Tisell LE. World J Surg 1996;20:854 commmonest cause of local recurrence is in the central lymph node compartment in the tracheo esophageal groove

22 lymph nodes do impact survival Swedish population study (n=5,123) nested case control study matched for age, sex and calendar year patients with lymph node metastases were more likely to die (OR, 2.5; 95% CI, ) still significant after adjustment for TNM (OR, 1.9; 95% CI ) Lundgren CI, Hall P.. Zedenius J. Cancer 2006;106:524 31

23 typical case 42 female with PTC total thyroidectomy 4 doses of radioiodine over 6 years because of a persistently elevated serum Tg 15 yrs later local recurrence left central neck managed by selective Level VI node dissection now Tg negative for the first time ever

24 total Tx +prophylactic CND surgical equipoise clearance of local disease acceptable operative risks

25 why routine prophylactic metastases in this area are not reliably identified by preoperative high resolution ultrasound moreover they are not easily identified at operation by palpation as they often lie in the tracheoesophageal groove deep to the RLN Marshall CL, Lee JE, Xing Y, Perrier ND, Edeiken BS, Evans DB, et al. Surgery. 2009;146:1063

26 initial Sydney data retrospective cohort study total thyroidectomy alone vs total thyroidectomy plus prophylactic ipsilateral central lymph node dissection pre op node negative neck clinically and on routine ultrasound histologically proven PTC >1cm lateral lymph node involvement beyond level VI excluded Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Surgery. 2006;140:1000

27 post ablative serum TG levels Serum TG ug/l 6 12 months No of 131 I treatments * Stimulated TG levels 0.95 Group A TTx+LND 0.41 Group B TTx Group A Group B *P=0.02 P=0.51

28 study conclusion no difference in permanent complications routine prophylactic ipsilateral central lymph node dissection can be performed safely associated with significantly lower levels of stimulated thyroglobulin following 131 I ablation. results in higher rates of athyroglobulinemia when compared with total thyroidectomy alone Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Surgery. 2006;140:1000

29 Michigan data 143 patients with clinically node negative PTC no difference in stimulated serum thyroglobulin levels and the number of patients with undetectable stimulated thyroglobulin levels post op and at 1 year the presence of involved central neck lymph nodes upstaged 28.6% of patients questions the potential for any long term benefit of prophylactic central node dissection, namely reduced long term central compartment recurrence Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM. Surgery. 2010;148:1100

30 Randolph editorial commentary prophylactic CND should not be performed no conclusive published data that prophylactic CND improves survival or local recurrence prophylactic CND frequently leads to microscopic pre clinical upstaging without evidence of therapeutic benefit only a small fraction of patients will ever require therapeutic CND if prophylactic CND is not performed the surgical skill is not readily available the presence of a surgical skill sufficient to perform a procedure is not an indication for the procedure Randolph GW. Surgery 2010;148:

31 Chernobyl data we believe prophylactic central compartment neck dissection was one of the major circumstances that decreased the chance of recurrence which in most instances (81.2% sites cumulatively) manifested as regional metastasis guideline based surgical treatment significantly reduced local recurrence (HR = 0.17, 95% CI = ) Rumyantsev PO, Saenko VA, Iilyn AA... Yamashita S. J Clin Endocrinol Metab 2011;96:

32 multicenter study A Multicenter Cohort Study of Total Thyroidectomy versus Total Thyroidectomy and Prophylactic Central Lymph Node Dissection University of Sydney Endocrine Surgical Unit Endocrine Surgical Unit, UCLA, California Dept Endocrine Surgery, Hammersmith Hospital 606 patients with papillary cancer > 1cm node negative on clinical and ultrasound 347 had prophylactic central node dissection 259 had total thyroidectomy only Popadich A...Delbridge L, Yeh M. Presented at AAES Annual Meeting, Texas, April 2011 (in press Surgery)

33 results 1 in the prophylactic CND group, 127 patients (49%) had nodal metastatic disease proven at final histology. ipsilateral CND was performed in 203 (78%) patients, and 56 (22%) had bilateral CND in the study population as a whole a total of 28 (5%) patients were upstaged according to the AJCC staging system for differentiated thyroid cancer.

34 results 2 in the group having prophylactic central node dissection: stimulated thyroglobulin levels were significantly lower prior to initial radio iodine ablation (15.0 versus 6.6ng/ml, p=0.025) the rate of re operative surgery in the central compartment was significantly lower (1.5 versus 6.1%, p=0.004). the calculated number of CND procedures required to prevent one central compartment re operation was 20.

35 complications No CND PCND temporary hypocalcemia 4.1% 9.7% (p=0.026) permanent hypoparathyroidsim 0.5% 0.4% temporary RLN neuropraxia 2.3% 0.4% permanent RLN palsy 1.8% 0.4% hematoma 0.9% 1.8% wound infection 1.4% 1.2% parathyroid glands autotransplanted (mean) (p=0.006)

36 multicenter study conclusion routine CND for cn0 PTC can be performed at the time of initial surgery with no apparent increase in long term morbidity. routine CND results in a lowering of the initial preablation stimulated serum thyroglobulin greatly facilitating long term follow up management routine CND in addition to total thyroidectomy is associated with a lower recurrence rates of PTC and a significant reduction in the need for re operation in the central compartment Popadich A...Delbridge L, Yeh M. Presented at AAES Annual Meeting, Texas, April 2011 (in press Surgery)

37 unilateral or bilateral CND? increased risk of permanent complications vs better clearance of involved nodes?

38 increased morbidity of bilateral CND 110 patients with PTC bilateral CND 77% had lymph node metastases 86% temporary hypocalcaemia 5% permanent hypoparathyroidism no CND 61% temporary hypocalcaemia no permanent hypoparathyroidism Rosenbaum MA, McHenry CR. Arch Otolaryngol Head Neck Surg 2009;135:1092

39 Mayo optimized surgical strategy 420 pts optimized up to 2006 near total thyroidectomy bilateral CND after routine ultrasound lateral dissection II/IV/VI + II if node +ve 5% developed LN recurrence in previously operated fields permanent hypoparathyroidism 1.2% and recurrent laryngeal nerve division 0.3% Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. World J Surg. 2010;34:1239

40 for what benefit? 21 patients with bilateral node clearance vs 75 patients with unilateral level 6 clearance no effect on serum thyroglobulin levels temporary hypocalcemia 48% vs 20% the more conservative unilateral dissection is safer and as effective as bilateral clearance Lee YS, Kim SW... Chung KW. World J Surg 2007;31:1954

41 ? selective based on size routine bilateral CND with separate analysis of left and right basins tumor <1cm none had bilateral nodes tumour > 1cm 33% ipsilateral positive nodes 20% bilateral positive nodes favours bilateral CND for larger tumors Moo TA, Umunna B, Kato M et al. Ann Surg 2009;250:403

42 prophylactic central + lateral neck dissection extensive disease clearance significant morbidity post op

43 Gustave Roussy approach 115 pts routine prophylactic CND + LND for PTC < 2cm (negative cervical ultrasound) complications < 1% 97% had undetectable thyroglobulin levels Bonnet S, Hart D, Leboullex S et al. J Clin Endocrinol Metab 2009;94:1162 clear evidence of harm exceeding benefit for prophylactic central + lateral neck dissection Steward DL..in Mazzaferi EL et al. Thyroid 2009;19:683

44 Sydney surgical equipoise over 85% of patients will have low risk papillary thyroid cancer for the typical patient total thyroidectomy + prophylactic unilateral CND provides the best balance selective use of prophylactic bilateral CND clearance of local disease acceptable operative risks

45 central nodes 1 prelaryngeal (Delphian) nodes notch of thyroid cartilage to cricoid and top of isthmus remove pyramid and clear cricothyroid membrane

46 prelaryngeal nodes

47 central nodes 2 pretracheal nodes bottom of isthmus to sternal notch laterally to medial border of each thymus, clearing all tissue to tracheal surface

48 pretracheal nodes

49 central nodes 3 (level VII) retromanubrial nodes sternal notch to innominate vein simply the caudal continuation of the pretracheal dissection remaining medial to each thymus

50 retromanubrial nodes

51 central nodes 4 right paratracheal nodes follows RLN from inferior thyroid artery to common carotid continuous with paratracheal dissection removing thymus and tissue in tracheo esophageal groove

52 parathyroid autotransplantation the inferior parathyroid gland always lies within the operative field thyroid capsule thyrothymic tract if it is not found and transplanted it is lost

53 parathyroid autotransplantation

54 right paratracheal nodes

55 central nodes 5 left paratracheal nodes follows RLN from inferior thyroid artery to thoracic inlet continuous with paratracheal dissection removing thymus and tissue in tracheo esophageal groove

56 left paratracheal nodes

57 ? tailored procedure risk of complications can be minimized by tailored procedures based on size of tumor location of tumor New York study: tumor <1cm none had bilateral nodes tumour > 1cm 33% ipsilateral positive nodes 20% bilateral positive nodes Moo TA, Umunna B, Kato M et al. Ann Surg 2009;250:403

58 unilateral dissection eg small tumor, superior pole delphian, pretracheal +ipsilateral paratracheal

59 bilateral dissection eg large tumor, inferior pole or central delphian, pretracheal, bilateral paratracheal + retromanubrial

60 take home messages most patients have low risk papillary thyroid cancer and will do very well however lymph node involvement does impact survival clinically evident node, central or lateral disease requires therapeutic dissection for the typical patient total thyroidectomy + prophylactic unilateral central node dissection CND provides the best balance in reducing the risk of local recurrence selective use of prophylactic bilateral CND

61 teşekkür ederim

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

Disclosures Nodal Management in Differentiated Thyroid Carcinoma Disclosures Nodal Management in Differentiated Thyroid Carcinoma Nothing to disclose Jonathan George, MD, MPH Assistant Professor UCSF Head and Neck Oncologic & Endocrine Surgery Objectives Overview Describe

More information

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con Christopher R. McHenry, M.D. Vice Chairman Department of Surgery MetroHealth Medical Center Professor of Surgery

More information

Persistent & Recurrent Differentiated Thyroid Cancer

Persistent & Recurrent Differentiated Thyroid Cancer Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of

More information

Reoperative central neck surgery

Reoperative central neck surgery Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University

More information

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies

More information

The clinical prognosis of patients with cn0 papillary thyroid microcarcinoma by central neck dissection

The clinical prognosis of patients with cn0 papillary thyroid microcarcinoma by central neck dissection Zhang et al. World Journal of Surgical Oncology (2015) 13:138 DOI 10.1186/s12957-015-0553-2 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access The clinical prognosis of patients with cn0 papillary

More information

Gerard M. Doherty, MD

Gerard M. Doherty, MD Surgical Management of Differentiated Thyroid Cancer: Update on 2015 ATA Guidelines Gerard M. Doherty, MD Chair of Surgery Utley Professor of Surgery and Medicine Boston University Surgeon-in-Chief Boston

More information

What? When? Why? (How?)

What? When? Why? (How?) Surgery of the Central Neck in Thyroid Cancer Dana M Hartl MD PhD Haïtham Mirghani MD Nothing to disclose Disclosure 2 Central Neck Dissection What? When? Why? (How?) What is it? Terminology for neck dissection

More information

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies

More information

Current Issues in Thyroid Cancer Surgery in 2017

Current Issues in Thyroid Cancer Surgery in 2017 Current Issues in Thyroid Cancer Surgery in 2017 Dr. David Goldstein MD Msc FRCSC FACS Associate Professor, Department Otolaryngology Head & Neck Surgery, U of T Department of Surgical Oncology, Princess

More information

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Well Differentiated Thyroid Cancer Natural History and Prognosis EORTC AGES AMES MACIS QuickTime and a TIFF (LZW) decompressor

More information

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been

More information

Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study

Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study Original Article Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study Qiang Chen, Xiu-He Zou, Tao Wei, Qiu-Shi Huang,

More information

Surgery for Recurrent Thyroid cancer: Considerations and limitations

Surgery for Recurrent Thyroid cancer: Considerations and limitations Surgery for Recurrent Thyroid cancer: Considerations and limitations 2016 Thyroid Master Class February 13, 2016 Ara A. Chalian MD, FACS Surgical Patient Safety Officer University Of Pennsylvania Health

More information

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,

More information

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?

More information

The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma

The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma Original Research Article The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma Nived Rao 1, M. Muralidhar 2*, M. Srinivasulu 3 1Senior Resident in Surgical

More information

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey. Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:

More information

Management of Recurrent Thyroid Cancer

Management of Recurrent Thyroid Cancer Management of Recurrent Thyroid Cancer Eric Genden, MD, MHA Isidore Professor and Chairman Department of Otolaryngology- Head and Neck Surgery Senior Associate Dean for Clinical Affairs The Icahn School

More information

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients ORIGINAL ARTICLE Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients Jianbiao Wang, MM, 1 Haili Sun, BM,

More information

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD ORIGINAL ARTICLE ELECTIVE PARATRACHEAL NECK DISSECTION FOR LATERAL METASTASES FROM PAPILLARY CARCINOMA OF THE THYROID: IS IT INDICATED? Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler,

More information

Dr J K Jekel Dept. Surgery University of Pretoria

Dr J K Jekel Dept. Surgery University of Pretoria Dr J K Jekel Dept. Surgery University of Pretoria No Maybe ( T`s and C`s apply ) 1. Total thyroidectomy 2. Neck dissection only if nodes are involved 3. Ablative dose or doses of Radioactive Iodine 4.

More information

Central Lymph Node Dissection In Patients With Papillary Thyroid Cancer: A Population Level Analysis Of Cases

Central Lymph Node Dissection In Patients With Papillary Thyroid Cancer: A Population Level Analysis Of Cases Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2013 Central Lymph Node Dissection In Patients With Papillary

More information

Preoperative Evaluation

Preoperative Evaluation Preoperative Evaluation Lateral compartment lymph nodes are easier to detect and are amenable to FNA Central compartment lymph nodes are much more difficult to detect and FNA (Tg washout testing is compromised)

More information

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer DEBATE WJOES Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Ashok R Shaha

More information

유두상갑상선암종에서경부림프절전이의양상및치료

유두상갑상선암종에서경부림프절전이의양상및치료 KISEP Head and Neck Korean J Otolaryngol 2005;48:506- 유두상갑상선암종에서경부림프절전이의양상및치료 태경 전성하 이현창 김경래 이형석 박용수 2 안유헌 2 김태화 2 Pattern and Treatment of Papillary Thyroid Carcinoma with Cervical Lymph Node Metastasis

More information

Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus

Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus ORIGINAL ARTICLE Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus Chang Myeon Song, MD, 1 Dong Won Lee, MD, 1 Yong Bae Ji, MD, PhD, 1 Jin Hyeok Jeong,

More information

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary Surgery for Well-differentiated Thyroid Carcinoma- The Primary Head and Neck Endocrine Surgery Department of Otolaryngology-Head and Neck Surgery, UCSF October 24-25, 2008 Robert A. Sofferman, MD Professor

More information

Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma

Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma Int J Clin Exp Pathol 2013;6(3):510-515 www.ijcep.com /ISSN:1936-2625/IJCEP1211043 Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma

More information

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel

More information

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S.

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma David W. Eisele, M.D., F.A.C.S. Head and Neck Surgery and Oncology U.C.S.F. Comprehensive Cancer Center University of California,

More information

WTC 2013 Panel Discussion: Minimal disease

WTC 2013 Panel Discussion: Minimal disease WTC 2013 Panel Discussion: Minimal disease Susan J. Mandel MD MPH Panelists Ken Ain Yasuhiro Ito Stephanie Lee Erich Sturgis Mark Urken Faculty/Presenter Disclosure Relationships with commercial interests

More information

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with

More information

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Bangladesh J Otorhinolaryngol 2010; 16(2): 126-130 Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Md. Abdul Mobin Choudhury 1, Md. Abdul Alim Shaikh

More information

Bilateral Papillary Thyroid Cancer Increases the Risk of Lymph Node Metastasis Compared with Unilateral Multifocal Papillary Thyroid Cancer

Bilateral Papillary Thyroid Cancer Increases the Risk of Lymph Node Metastasis Compared with Unilateral Multifocal Papillary Thyroid Cancer J Endocr Surg. 2017 Jun;17(2):63-72 pissn 2508-8149 eissn 2508-8459 Original Article Bilateral Papillary Thyroid Cancer Increases the Risk of Lymph Node Metastasis Compared with Unilateral Multifocal Papillary

More information

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting?

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Jacob Moalem, MD, FACS Associate Professor Endocrine Surgery and Endocrinology URMC Agenda 1. When is lobectomy alone

More information

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans 131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans Anca M. Avram, M.D. Associate Professor of Radiology Department of Nuclear Medicine University of Michigan Ann Arbor,

More information

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status New Perspectives in Thyroid Cancer Jennifer Sipos, MD Assistant Professor of Medicine Division of Endocrinology The Ohio State University Outline Thyroid Nodules Thyroid Cancer Epidemiology Initial management

More information

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits?

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits? Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits? Julie Ann Sosa, MD MA FACS Professor of Surgery and Medicine Chief, Section of Endocrine

More information

2. Patients & Methods

2. Patients & Methods Journal of Surgery 2017; 5(6): 124-129 http://www.sciencepublishinggroup.com/j/js doi: 10.11648/j.js.20170506.17 ISSN: 2330-0914 (Print); ISSN: 2330-0930 (Online) Total Thyroidectomy Without Prophylactic

More information

Accepted 12 August 2013 Published online 27 November 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23451

Accepted 12 August 2013 Published online 27 November 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23451 ORIGINAL ARTICLE Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: A single-center study in China Zhang Pinyi,

More information

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK

More information

THYROID & PARATHYROID. By Prof. Saeed Abuel Makarem & Dr. Sanaa Al-Sharawy

THYROID & PARATHYROID. By Prof. Saeed Abuel Makarem & Dr. Sanaa Al-Sharawy THYROID & PARATHYROID By Prof. Saeed Abuel Makarem & Dr. Sanaa Al-Sharawy 1 OBJECTIVES By the end of the lecture, the student should be able to: Describe the shape, position, relations and structure of

More information

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose. Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for

More information

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50% Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake

More information

Risk Adapted Follow-Up

Risk Adapted Follow-Up Risk Adapted Follow-Up Individualizing Follow- Up Strategies R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College

More information

Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan, KY; Lo, CY. Citation World Journal of Surgery, 2013, v. 37 n. 12, p

Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan, KY; Lo, CY. Citation World Journal of Surgery, 2013, v. 37 n. 12, p Title Evaluating the Morbidity and Efficacy of Reoperative Surgery in the Central Compartment for Persistent/Recurrent Papillary Thyroid Carcinoma Author(s) Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan,

More information

Clinical value and indication for the dissection of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma

Clinical value and indication for the dissection of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma /, 2017, Vol. 8, (No. 45), pp: 79897-79905 Clinical value and indication for the dissection of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma Ding-Cun Luo 1,

More information

Review Article Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma

Review Article Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma SAGE-Hindawi Access to Research Thyroid Research Volume 2011, Article ID 634170, 6 pages doi:10.4061/2011/634170 Review Article Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma Yasuhiro

More information

Thyroidectomy. Siu Kwan Ng. Modified Radical Neck Dissection Type II 47

Thyroidectomy. Siu Kwan Ng. Modified Radical Neck Dissection Type II 47 06 Thyroidectomy Siu Kwan Ng Modified Radical Neck Dissection Type II 47 Thyroidectomy STEP 1. EXPOSING THE THYROID GLAND The collar incision Figure 1 (curvilinear skin crease incision) is made at 1.5-2

More information

Long Term Follow-Up for Differentiated Thyroid Cancer: The Mayo Experience

Long Term Follow-Up for Differentiated Thyroid Cancer: The Mayo Experience Long Term Follow-Up for Differentiated Thyroid Cancer: The Mayo Experience Geoffrey B. Thompson, MD Professor of Surgery College of Medicine, Mayo Clinic Differentiated Thyroid Cancer Objectives Overview

More information

Surgical anatomy of thyroid and parathyroid glands

Surgical anatomy of thyroid and parathyroid glands Head & Neck Surgery Course Surgical anatomy of thyroid and parathyroid glands Dr Pierfrancesco PELLICCIA Pr Benjamin LALLEMANT Service ORL et CMF CHU de Nîmes CH de Arles Thyroid glands Dr Pierfrancesco

More information

Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection

Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection Deutschmann et al. Journal of Otolaryngology - Head and Neck Surgery (2016) 45:55 DOI 10.1186/s40463-016-0169-8 ORIGINAL RESEARCH ARTICLE Open Access Practice patterns among thyroid cancer surgeons: implications

More information

Lymph node management in clinically node-negative patients with papillary thyroid carcinoma

Lymph node management in clinically node-negative patients with papillary thyroid carcinoma Lymph node management in clinically node-negative patients with papillary thyroid carcinoma S. Vergez, J. Sarini, J. Percodani, E. Serrano, Ph Caron To cite this version: S. Vergez, J. Sarini, J. Percodani,

More information

PEDIATRIC Ariel Katz MD

PEDIATRIC Ariel Katz MD PEDIATRIC Ariel Katz MD Dept. Otolaryngology Head &Neck Surgery Wolfson Medical Center Holon, Israel OBJECTIVES Overview/Background Epidemiology/Etiology Intro to Guidelines Workup Treatment Follow-Up

More information

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &

More information

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines 2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results

More information

Department of Surgery, Eulji University College of Medicine, Seoul, Republic of Korea 2

Department of Surgery, Eulji University College of Medicine, Seoul, Republic of Korea 2 Journal of Oncology Volume 2012, Article ID 734541, 9 pages doi:10.1155/2012/734541 Clinical Study Robotic versus Endoscopic Thyroidectomy for Thyroid Cancers: A Multi-Institutional Analysis of Early Postoperative

More information

Title. Lang, BHH; Tang, AH; Wong, KP; Shek, TW; Wan, KY; Lo, CY. Citation Annals of Surgical Oncology, 2012, v. 19 n. 11, p.

Title. Lang, BHH; Tang, AH; Wong, KP; Shek, TW; Wan, KY; Lo, CY. Citation Annals of Surgical Oncology, 2012, v. 19 n. 11, p. Title Significance of Size of Lymph Node Metastasis on Postsurgical Stimulated Thyroglobulin Levels After Prophylactic Unilateral Central Neck Dissection in Papillary Thyroid Carcinoma Author(s) Lang,

More information

Lies in front and sides of the neck. Consists of two lobe connected anterior to the trachea by an isthmus.

Lies in front and sides of the neck. Consists of two lobe connected anterior to the trachea by an isthmus. THYROID GLAND 1 Lies in front and sides of the neck. Consists of two lobe connected anterior to the trachea by an isthmus. A small pyramidal lobe projects upwards from the left lobe in 40% of cases. The

More information

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica

More information

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016 Outcomes from the diagnostic approach of thyroid lesions using US-FNA and LBC in clinical practice Emmanouel Mastorakis MD PhD Cytopathologist Director in Cytopathology Laboratory Regional General Hospital

More information

Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence

Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence ORIGINAL ARTICLE Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence Young Min Park, MD, PhD, 1 Soo-Geun Wang, MD, PhD,

More information

American Head and Neck Society - Journal Club Volume 22, July 2018

American Head and Neck Society - Journal Club Volume 22, July 2018 - Table of Contents click the page number to go to the summary and full article link. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated

More information

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation Case Report American Journal of Cancer Case Reports http://ivyunion.org/index.php/ajccr/ Page 1 of 6 Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation Ammara

More information

The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer

The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer Original Article Yonsei Med J 2015 Nov;56(6):1632-1637 pissn: 0513-5796 eissn: 1976-2437 The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer Hojin Chang 1, Ri

More information

ORIGINAL ARTICLE. The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer

ORIGINAL ARTICLE. The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer ORIGINAL ARTICLE The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer Maisie Shindo, MD; James C. Wu, MD; Eunice E. Park, MPH; Frances

More information

Thyroid and Parathyroid Glands

Thyroid and Parathyroid Glands Thyroid and Parathyroid Glands Please view our Editing File before studying this lecture to check for any changes. Color Code Important Doctors Notes Notes/ explanation Objectives: By the end of the lecture,

More information

Lecture 01. The Thyroid & Parathyroid Glands. By: Dr Farooq Khan PMC Date: 12 th March. 2018

Lecture 01. The Thyroid & Parathyroid Glands. By: Dr Farooq Khan PMC Date: 12 th March. 2018 Lecture 01 The Thyroid & Parathyroid Glands By: Dr Farooq Khan PMC Date: 12 th March. 2018 INTRODUCTION LAYERS OF THE NECK The neck has four major compartments or layer which are enclosed by an outer musculofascial

More information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information Title Lymph node metastasis in the suprasternal space from Homma, Akihiro; Hatakeyama, Hiromitsu; Mizumachi, Ta Author(s) Tomohiro; Fukuda, Satoshi CitationInternational Cancer Conference Journal, 4(1):

More information

Thyroid Cancer & rhtsh: When and How?

Thyroid Cancer & rhtsh: When and How? Thyroid Cancer & rhtsh: When and How? 8 th Postgraduate Course in Endocrine Surgery Capsis Beach, Crete, September 21, 2006 Quan-Yang Duh, Professor of Surgery, UCSF Increasing Incidence of Thyroid Cancer

More information

Citation Annals of Surgical Oncology, 2014, v. 21, n. 3, p The original publication is available at

Citation Annals of Surgical Oncology, 2014, v. 21, n. 3, p The original publication is available at Title A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma Author(s) Wong, Carlos K. H.; Lang, Brian Citation Annals of Surgical Oncology,

More information

Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer

Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer Original Article Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer David Yü Greenblatt, Diane Elson, 1 Eberhard Mack and Herbert Chen, Departments of Surgery

More information

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer A rational approach to longterm follow-up based on dynamic risk assessment. World Congress on Thyroid

More information

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries REVIEW ARTICLE J Korean Thyroid Assoc Vol. 4, No. 2, November 2011 Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries Yasuhiro Ito, MD and Akira Miyauchi, MD

More information

Thyroid Neoplasm. ORL-Head and neck Surgery 2014

Thyroid Neoplasm. ORL-Head and neck Surgery 2014 In The Name of God Thyroid Neoplasm ORL-Head and neck Surgery 2014 Malignant Neoplasm By age 90, virtually everyone has nodules Estimates of cancer prevalence at autopsy 4% to 36% Why these lesions are

More information

ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease

ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease Richard T. Kloos, M.D. The Ohio State University Divisions of Endocrinology and Nuclear Medicine

More information

A Closer Look at Parathyroid Anatomy During Thyroid Surgery

A Closer Look at Parathyroid Anatomy During Thyroid Surgery BMH Medical Journal 2014;1(4):66-71 Research Article A Closer Look at Parathyroid Anatomy During Thyroid Surgery PV Pradeep MS, DNB, MRCSEd, MCh (Endocrine Surgery) Department of Endocrine Surgery, Baby

More information

Dynamic Risk Stratification:

Dynamic Risk Stratification: Dynamic Risk Stratification: Using Risk Estimates to Guide Initial Management R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine

More information

Case Report Occult thyroid carcinoma: a rare case report and review of literature

Case Report Occult thyroid carcinoma: a rare case report and review of literature Int J Clin Exp Pathol 2014;7(8):5210-5214 www.ijcep.com /ISSN:1936-2625/IJCEP0001034 Case Report Occult thyroid carcinoma: a rare case report and review of literature Haiguang Liu, Lin Lv, Kai Yang Department

More information

ORIGINAL ARTICLE. Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid

ORIGINAL ARTICLE. Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid ORIGINAL ARTICLE Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid Akira Ohshima, MD, PhD; Hiroyuki Yamashita, MD, PhD; Shiro Noguchi, MD, PhD;

More information

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh

More information

Avoiding Disaster in Thyroid Surgery: 5 Critical Principles

Avoiding Disaster in Thyroid Surgery: 5 Critical Principles Avoiding Disaster in Thyroid Surgery: 5 Critical Principles David J. Terris, M.D. 1 William S. Duke, M.D. 2 Department of Otolaryngology-Head & Neck Surgery 1 Augusta University 2 MultiCare Health System

More information

Imaging in Thyroid Cancer

Imaging in Thyroid Cancer Imaging in Thyroid Cancer Susan J. Mandel MD MPH University of Pennsylvania School of Medicine Philadelphia, PA I-123 Ultrasound Background Radioiodine ablation of thyroid remnants after surgery is a generally

More information

Risk factors of lateral lymph node metastasis in cn0 papillary thyroid carcinoma

Risk factors of lateral lymph node metastasis in cn0 papillary thyroid carcinoma Hu et al. World Journal of Surgical Oncology (2018) 16:30 https://doi.org/10.1186/s12957-018-1336-3 RESEARCH Open Access Risk factors of lateral lymph node metastasis in cn0 papillary thyroid carcinoma

More information

Revision Neural Monitored Surgery for Recurrent Thyroid Cancer: Safety and Thyroglobulin Response

Revision Neural Monitored Surgery for Recurrent Thyroid Cancer: Safety and Thyroglobulin Response The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. Revision Neural Monitored Surgery for Recurrent Thyroid Cancer: Safety and Thyroglobulin Response Behzad

More information

Clinical Guidance in Thyroid Cancers. Stephen Robinson Imperial at St Mary s On behalf of BTA

Clinical Guidance in Thyroid Cancers. Stephen Robinson Imperial at St Mary s On behalf of BTA Clinical Guidance in Thyroid Cancers Stephen Robinson Imperial at St Mary s On behalf of BTA Background to thyroid cancer Incidence probably increasing slowly 1971-95; 2.3 women 0.9 men /100,000 2001;

More information

Fuqiang Li, Yijun Wu, Liang Chen, Liang Hu, Xiaosun Liu. Original Article

Fuqiang Li, Yijun Wu, Liang Chen, Liang Hu, Xiaosun Liu. Original Article Original Article Page 1 of 11 Evaluation of clinical risk factors for predicting insidious right central and posterior right recurrent laryngeal nerve lymph node metastasis in papillary thyroid microcarcinoma

More information

Elective Central Compartment Neck Dissection in Patients With Papillary Thyroid Carcinoma Recurrence

Elective Central Compartment Neck Dissection in Patients With Papillary Thyroid Carcinoma Recurrence The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Elective Central Compartment Neck in atients With apillary Thyroid Carcinoma Recurrence Omer Trivizki, MD;

More information

New York, the nation s thyroid gland. Christopher Morley ( ), "Shore Leave"

New York, the nation s thyroid gland. Christopher Morley ( ), Shore Leave New York, the nation s thyroid gland Christopher Morley (1890-1957), "Shore Leave" Thyroid Literature Medline Thyroid disease 136,053 Thyroid tumors 33,554 New Paper on Thyroid Disease Every 3 Hours New

More information

Evaluation of the Outcome of Patients with Papillary Thyroid Carcinoma with Surgical Intervention

Evaluation of the Outcome of Patients with Papillary Thyroid Carcinoma with Surgical Intervention Chattagram Maa-O-Shishu Hospital Medical College Journal Original Article Evaluation of the Outcome of Patients with Papillary Thyroid Carcinoma with Surgical Intervention Sumon Rahman Chowdhury 1* Yarmus

More information

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD

More information

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2 1 di 5 11/04/2016 17:54 G Chir Vol. 31 - n. 5 - pp. 205-209 Maggio 2010 Y-N XU 1,2, J-D WANG 1,2 Introduction The World Health Organization (WHO) defined papillary thyroid microcarcinomas (PTMC) as tumors

More information

How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017

How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017 How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017 Bryan R. Haugen, MD University of Colorado, School of Medicine Outline Some statistics New guidelines

More information

Differentiated Thyroid Cancer: Initial Management

Differentiated Thyroid Cancer: Initial Management Page 1 ATA HOME GIVE ONLINE ABOUT THE ATA JOIN THE ATA MEMBER SIGN-IN INFORMATION FOR PATIENTS FIND A THYROID SPECIALIST Home Management Guidelines for Patients with Thyroid Nodules and Differentiated

More information

Oncological outcomes for patients with well differentiated thyroid cancer Nixon, I.J.

Oncological outcomes for patients with well differentiated thyroid cancer Nixon, I.J. UvA-DARE (Digital Academic Repository) Oncological outcomes for patients with well differentiated thyroid cancer Nixon, I.J. Link to publication Citation for published version (APA): Nixon, I. J. (2013).

More information

Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma

Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma Kim et al. World Journal of Surgical Oncology 2012, 10:226 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid

More information

Solitary lateral neck node metastasis in papillary thyroid carcinoma

Solitary lateral neck node metastasis in papillary thyroid carcinoma Kim et al. World Journal of Surgical Oncology 2014, 12:109 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Solitary lateral neck node metastasis in papillary thyroid carcinoma Seok-Mo Kim, Ki Won

More information

BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma

BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma ORIGINAL ARTICLE BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma Seo Ki Kim, MD, 1 Jun Ho Lee, MD, 2 Jung-Woo Woo, MD, 1 Inhye Park,

More information

Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma Patients

Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma Patients International Endocrinology Volume 2016, Article ID 1878194, 5 pages http://dx.doi.org/10.1155/2016/1878194 Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma

More information